# M21 Phase 7 — readiness report (draft)

**Overall:** `INCOMPLETE` — draft infrastructure only. Readiness cannot be promoted
by caller-supplied status strings; canonical adapters and the full test-matrix
evidence are missing. No biological benchmark is authorized.

| Area | Status | Evidence / limitation |
|---|---|---|
| Multi-artifact inventory and exclusion | PASS for covered synthetic cases | Validates signed inventory, actual bytes, all files, cross-file IDs, shared resource limits, and per-artifact results. |
| Aggregate scientific approval | PASS for covered synthetic case | Approval binding includes snapshot, inventory, policy, aggregate evidence, exact review, and approval-set digests. |
| Independent custody interface | PASS for covered synthetic cases | Compares retained checkpoints with local event prefixes, authenticates checkpoint rotation, permits a valid uncheckpointed suffix, and rejects missing required local history. External source independence remains a caller responsibility. |
| Artifact-backed transition bytes | PARTIAL | Reopens, caps, parses, and rehashes required typed artifacts. Caller callbacks are ignored; canonical trusted Phase 4–6 stage adapters are not yet shipped. |
| Adversarial suite | PARTIAL | Synthetic tests cover panel inventory/resource failures, approval binding, checkpoint rollback/replacement and suffix handling, plus transition byte mutation and refusal to execute custom PASS callbacks. The complete 27-case acceptance matrix remains pending. |
| Reports and schemas | PASS for covered schema checks | Draft 2020-12 metaschema checks and valid/invalid instances pass locally; wheel inspection confirms all three schemas are packaged. |
| Biological execution authorization | BLOCKED | Fixed state remains `BLOCKED_FOR_BENCHMARK_EXECUTION`. |

No real sequences, FASTQ/FASTA datasets, credentials, or truth keys were used.
Phase 5 scoring definitions and M1–M20 interfaces are unchanged.

## Recommended Phase 8 scope

After Phase 7 reaches `PASS`, evaluate a reproducible synthetic-only rerun
against independently retained checkpoints and pinned artifact inventories.
Keep biological execution blocked until a separate, authenticated governance
decision addresses scientific validity and data access.
